Download GlobalData’s Covid-19 Executive Briefing report
- ECONOMIC IMPACT -
Latest update: 25 January 2022
Hiring prospects for Pharma continue to improve and the Pharma Jobs index grew by 40.6% to date
The momentum of global economic growth is expected to weaken in 2022 amid uncertainty
Global growth is expected to be moderate at 4.4% compared to 5.9% in 2021 as per the IMF
Inflation rose by 7% in the US in December 2021 from the previous year
IMPACT OF COVID-19 ON JOBS
- SECTOR IMPACT: PHARMA -
Latest update: 2 February 2022
Number of disrupted trials due to Covid-19. Suspended trials have begun to recruit participants, but the impact on trials resulting in slow recruitment is still on the rise
Germany has a high booster dose penetration with 45% of people fully vaccinated with a booster while only 18% in Spain are boosted.
Covid-19 lockdown and social distancing measures forced Pharma to rapidly implement new ways of engaging with customers, and promoting their brands and messaging.
This includes increased online marketing on social media like Facebook and LinkedIn, especially as more people are online since the pandemic began.
As per an ongoing poll on Pharmaceutical Technology and Clinical Trials Arena sites, 82% of respondents say the pandemic has led to an increase in the use of social media accounts by Pharma companies